These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 2826614)

  • 1. Studies of prototype live hepatitis A virus vaccines in primate models.
    Karron RA; Daemer R; Ticehurst J; D'Hondt E; Popper H; Mihalik K; Phillips J; Feinstone S; Purcell RH
    J Infect Dis; 1988 Feb; 157(2):338-45. PubMed ID: 2826614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evaluation of a live hepatitis A vaccine in marmosets.
    Provost PJ; Banker FS; Wadsworth CW; Krah DL
    J Med Virol; 1991 Aug; 34(4):227-31. PubMed ID: 1658214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A virus: growth characteristics of in vivo and in vitro propagated wild and attenuated virus strains.
    Bradley DW; Schable CA; McCaustland KA; Cook EH; Murphy BL; Fields HA; Ebert JW; Wheeler C; Maynard JE
    J Med Virol; 1984; 14(4):373-86. PubMed ID: 6096505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.
    Mao JS; Dong DX; Zhang HY; Chen NL; Zhang XY; Huang HY; Xie RY; Zhou TJ; Wan ZJ; Wang YZ
    J Infect Dis; 1989 Apr; 159(4):621-4. PubMed ID: 2538518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simian strain of hepatitis A virus, AGM-27, functions as an attenuated vaccine for chimpanzees.
    Emerson SU; Tsarev SA; Govindarajan S; Shapiro M; Purcell RH
    J Infect Dis; 1996 Mar; 173(3):592-7. PubMed ID: 8627022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental in vivo passage of H2 strain of live attenuated vaccine of hepatitis A in common marmosets].
    Huang X; Lian Y; Wang Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Sep; 31(5):260-2. PubMed ID: 9812599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in chimpanzees of live, attenuated hepatitis A vaccine candidates.
    Provost PJ; Conti PA; Giesa PA; Banker FS; Buynak EB; McAleer WJ; Hilleman MR
    Proc Soc Exp Biol Med; 1983 Mar; 172(3):357-63. PubMed ID: 6302710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward a live attenuated human hepatitis A virus vaccine.
    Hilleman MR; Provost PJ; Buynak EB; McLean AA
    Dev Biol Stand; 1983; 54():433-40. PubMed ID: 6317494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    Vaccine; 1992; 10 Suppl 1():S106-9. PubMed ID: 1335637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
    Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
    J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to nonstructural proteins of hepatitis A virus following infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    J Med Virol; 1993 May; 40(1):76-82. PubMed ID: 8390561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated vaccine for hepatitis A.
    Feinstone SM; Daemer RJ; Gust ID; Purcell RH
    Dev Biol Stand; 1983; 54():429-32. PubMed ID: 6317493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection.
    Robertson BH; D'Hondt EH; Spelbring J; Tian H; Krawczynski K; Margolis HS
    J Med Virol; 1994 Jul; 43(3):249-51. PubMed ID: 7931186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New findings in live, attenuated hepatitis A vaccine development.
    Provost PJ; Bishop RP; Gerety RJ; Hilleman MR; McAleer WJ; Scolnick EM; Stevens CE
    J Med Virol; 1986 Oct; 20(2):165-75. PubMed ID: 3021899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.
    Sjogren MH; Purcell RH; McKee K; Binn L; Macarthy P; Ticehurst J; Feinstone S; Caudill J; See A; Hoke C
    Vaccine; 1992; 10 Suppl 1():S135-7. PubMed ID: 1335645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.